Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial [NA]

View source ↗

Summary

A multicentre non-inferiority randomized trial compares 14-day vonoprazan-based dual therapy to quadruple therapy for Helicobacter pylori eradication; recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • METRONIDAZOLE (Metronidazole)
  • Vonoprazan (vonoprazan)
  • bismuth subcitrate (bismuth subcitrate)
  • tetracycline (tetracycline)

Snippet

Sponsor: Yanqing Li | Conditions: HELICOBACTER PYLORI INFECTIONS | NA | Status: RECRUITING